Advertisement

Cytotechnology

, Volume 31, Issue 1–2, pp 77–83 | Cite as

Effectiveness of vitamin A acetate for enhancing the production of lung cancer specific monoclonal antibodies

  • Yuichi Inoue
  • Mihoko Fujisawa
  • Seiji Kawamoto
  • Masahiro Shoji
  • Shuichi Hashizume
  • Makoto Fujii
  • Yoshinori Katakura
  • Sanetaka Shirahata
Article

Abstract

The antibody productivity of the human–human hybridoma cell line AE6, which produces the lung cancer specific human monoclonal antibody AE6F4, was enhanced fourfold upon stimulation with 1 μg/ml of vitamin A acetate for one day. The enhancement lasted for about two weeks, and could be repeated by another stimulation with vitamin A acetate. The enhancing effect of vitamin A acetate was influenced by the cell density. Enhancement was clearly observed when the cell density was under 106 cells/ml. However, when the cell density was over 107 cells/ml, enhancement was observed weakly or not at all. Although the enhancing effect of vitamin A acetate is not unique to AE6 cells, not all human–human hybridoma cell lines show increased productivity upon VA acetate stimulation. This study suggests that the response to vitamin A acetate may be related to the properties of a particular fusion partner which the hybridoma cell inherits. The efficacy of vitamin A acetate for production of human monoclonal antibodies using human–human hybridomas is discussed.

antibody production human monoclonalantibody hybridoma lung cancer vitamin A acetate 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aotsuka Y and Naito M (1991) Enhancing effects of retinoic acid on monoclonal antibody production of human-human hybridomas. Cell Immunol 133: 498–505.CrossRefGoogle Scholar
  2. Ballow M, Wang W and Xiang S (1996) Modulation of B-cell immunoglobulin synthesis by retinoic acid. Clin Immunol Immunopathol 80: 73–81.CrossRefGoogle Scholar
  3. Blomhoff HK, Smeland EB, Erikstein B, Rasmussen AM, Skrede B, Skjonsberg C and Blomhoff R (1992) Vitamin A is a key regulator for cell growth, cytokine production, and differentiation in normal B cells. J Biol Chem 267: 23988–23992.Google Scholar
  4. Chaiwun B, Saad A, Chatterjee SJ, Taylor CR, Beattie EJ and Cote RJ (1996) Advances in the pathologic staging of lung cancer: detection of regional and systemic occult metastases. Pathology Phila 4: 155–168.Google Scholar
  5. Chen AC and Gudas LJ (1996) An analysis of retinoic acid-induced gene expression and metabolism in AB1 embryonic stem cells. J Biol Chem 271: 14971–14980.CrossRefGoogle Scholar
  6. Desai D, Michalak M, Singh NK and Niles RM (1996) Inhibition of retinoic acid receptor function and retinoic acid-regulated gene expression in mouse melanoma cells by calreticulin. J Biol Chem 271: 15153–15159.CrossRefGoogle Scholar
  7. Eichele G (1989) Retinoids and vertebrate limb pattern formation. Trends Genet 5: 246–251.CrossRefGoogle Scholar
  8. Garbe A, Buck J and Hammerling U (1992) Retinoids are important cofactors in T cell activation. J Exp Med 176: 109–117.CrossRefGoogle Scholar
  9. Hespanhol V, Queiroga H, Magalhaes A, Santos AR, Coelho M and Marques A (1995) Survival predictiors in advanced non-small cell lung cancer. Lung cancer 13: 253–267.CrossRefGoogle Scholar
  10. Inoue Y, López LB, Kawamoto S, Arita N, Teruya K, Seki K, Shoji M, Kamei M, Hashizume S, Shiozawa Y, Tachibana H, Ohashi H, Yasumoto K, Nagashima A, Nakahashi H, Suzuki T, Imai T, Nomoto K, Takenouchi M, Katakura Y and Shirahata S (1996a) Production of recombinant human monoclonal antibody using ras-amplified BHK-21 cells in a protein-free medium. Biosci Biotech Biochem 60: 811–817.CrossRefGoogle Scholar
  11. Inoue Y, Kawamoto S, Seki K, Teruya K, Mochizuki K, Kato M, Hashizume S, Yasumoto K, Nagashima A, Nakahashi H, Suzuki T, Imai T, Nomoto K and Shirahata S (1996b) Production of a recombinant human monoclonal antibody using a novel hollow fiber bioreactor system. J Ferment Bioeng 81: 466–469.CrossRefGoogle Scholar
  12. Kawahara H, Shirahata S, Tachibana H and Murakami H (1992) In vitro immunization of human lymphocytes with human lung cancer cell line A549. Hum Antibod Hybridomas 3: 8–13.Google Scholar
  13. Kontani K, Nishina H, Ohoka Y, Takahashi K and Katada T (1993) NAD glycohydrolase specifically induced by retinoic acid in human leukemic HL-60 cells. Identification of the NAD glycohydrolase as leukocyte cell surface antigen CD38. J Biol Chem 268: 16895–16898.Google Scholar
  14. Minucci S, Leid M, Toyama R, Saint Jeannet JP, Peterson VJ, Horn V, Ishmael JE, Bhattacharyya N, Dey A, Dawid IB and Ozato K (1997) Retinoid X receptor (RXR) within the RXR-retinoic acid receptor heterodimer binds its ligand and enhances retinoid-dependent gene expression. Mol Cell Biol 17: 644–655.Google Scholar
  15. Murakami H, Hashizume S, Ohashi H, Shinohara K, Yasumoto K, Nomoto K and Omura H (1985) Human-human hybridomas secreting antibodies specific to human lung carcinoma. In Vitro Cell Dev Biol 21: 593–596.Google Scholar
  16. Nakayama H, Tsiboi M, Kaneko M and Naruke T (1996) Early lung cancer. Nippon Rinsho 54: 1359–1365.Google Scholar
  17. Pierce R, Irving L and Barter C (1996) Update on lung cancer. Aust Fam Physician 25: 177–179, 181, 184–188.Google Scholar
  18. Pomponi F, Cariati R, Zancai P, De Paoli P, Rizzo S, Tedeschi RM, Pivetta B, De Vita S, Boiocchi M and Dolcetti R (1996) Retinoids irreversibly inhibit in vitro growth of Epstein-Barr virus-immortalized B lymphocytes. Blood 88: 3147–3159.Google Scholar
  19. Rius C and Aller P (1992) Vimentin expression as a late event in the in vitro differentiation of human promonocytic cells. J Cell Sci 101: 395–401.Google Scholar
  20. Shoji M, Kawamoto S, Sato S, Kamei M, Kato M, Hashizume S, Seki K, Yasumoto K, Nagashima A, Nakahashi H, Suzuki T, Imai T, Nomoto K and Murakami H (1994a) Specific reactivity of human antibody AE6F4 against cancer cells in tissues and sputa from lung cancer patients. Hum Antibod Hybridomas 5: 116–122.Google Scholar
  21. Shoji M, Kawamoto S, Setoguchi Y, Mochizuki K, Honjoh T, Kato M, Hashizume S, Hanagiri T, Yoshimatsu T, Nakanishi K, Yasumoto K, Nagashima A, Nakahashi H, Suzuki T, Imai T, Nomoto K and Murakami H. (1994b) The 14–3–3 protein as the antigen for lung cancer-associated human monoclonal antibody AE6F4. Hum Antibod Hybridomas 5: 123–130.Google Scholar
  22. Suzuki E and Ollis DF (1990) Enhanced antibody production at slow growth rate: experimental demonstration and a simple structural model. Biotechnol Prog 6: 231–236.CrossRefGoogle Scholar
  23. Takahashi K, Tereda S, Ueda H, Makishima F and Suzuki E (1994) Growth rate suppression of cultured mammlian cells enhances protein productivities. Cytotechnology 15: 57–64.CrossRefGoogle Scholar
  24. Vu Dac N, Schoonjans K, Kosykh V, Dallongeville J, Heyman RA, Staels B and Auwerx J (1996) Retinoids increase human apolipoprotein A-II expression through activation of the retinoid X receptor but not the retinoic acid receptor. Mol Cell Biol 16: 3350–3360.Google Scholar
  25. Wang W, Napoli JL and Ballow M (1993) The effects of retinol on in vitro immunoglobulin synthesis by cord blood and adult peripheral blood mononuclear cells. Clin Exp Immunol 92: 164–168.CrossRefGoogle Scholar
  26. Yano T, Teruya K, Shirahata S, Watanabe J, Osada K, Tachibana H, Ohashi H, Kim EH and Murakami H (1994) Ras oncogene enhances the production of a recombinant protein regulated by the cytomegalovirus promoter in BHK-21 cells. Cytotechnology 16: 167–178.CrossRefGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1999

Authors and Affiliations

  • Yuichi Inoue
  • Mihoko Fujisawa
  • Seiji Kawamoto
  • Masahiro Shoji
  • Shuichi Hashizume
  • Makoto Fujii
  • Yoshinori Katakura
  • Sanetaka Shirahata

There are no affiliations available

Personalised recommendations